Literature DB >> 22528336

Association study of interleukin-4 polymorphisms with paranoid schizophrenia in the Polish population: a critical approach.

Anna Fila-Danilow1, Krzysztof Kucia, Malgorzata Kowalczyk, Aleksander Owczarek, Monika Paul-Samojedny, Paulina Borkowska, Renata Suchanek, Jan Kowalski.   

Abstract

Changes in immunological system are one of dysfunctions reported in schizophrenia. Some changes based on an imbalance between Th1 and Th2 cytokines results from cytokine gene polymorphisms. Interleukin-4 gene (IL4) is considered as a potential candidate gene in schizophrenia association studies. The aim of the current case-control study was to examine whether the -590C/T (rs2243250) and -33C/T (rs2070874) IL4 gene polymorphisms are implicated in paranoid schizophrenia development in the Polish population. Genotyping of polymorphisms was performed by using PCR-RFLP technique. The genotypes and alleles distribution of both SNPs were analysed in patients (n = 182) and healthy individuals constituted the control group (n = 215). The connection between some clinical variables and studied polymorphisms has been examined as well. We did not revealed any association between the -590C/T and -33C/T polymorphisms and paranoid schizophrenia. In case of both SNPs the homozygous TT genotype was extremely rare. Both polymorphic sites of the IL4 gene were found to be in a very strong linkage disequilibrium. However we did not identify a haplotype predispose to paranoid schizophrenia. No associations were also observed between the clinical course and psychopathology of the disease and the genotypes of both analysed polymorphisms. Our results suggest that the polymorphisms -590C/T in IL4 gene promoter region and -33C/T in the 5'-UTR are not involved in the pathophysiology of paranoid schizophrenia in Polish residents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528336     DOI: 10.1007/s11033-012-1639-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  42 in total

Review 1.  The role of immune function in schizophrenia: an overview.

Authors:  N Müller; M Riedel; M Ackenheil; M J Schwarz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 2.  Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?

Authors:  Koen Vandenbroeck; An Goris
Journal:  Trends Pharmacol Sci       Date:  2003-06       Impact factor: 14.819

3.  Frequencies of the common promoter polymorphisms in cytokine genes in a Polish population.

Authors:  M Kurzawski; A Pawlik; B Czerny; L Domański; J Rózański; M Droździk
Journal:  Int J Immunogenet       Date:  2005-10       Impact factor: 1.466

4.  Candidate genes for schizophrenia: a survey of association studies and gene ranking.

Authors:  Jingchun Sun; Po-Hsiu Kuo; Brien P Riley; Kenneth S Kendler; Zhongming Zhao
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

5.  Microglia dysfunction in schizophrenia: an integrative theory.

Authors:  N A Munn
Journal:  Med Hypotheses       Date:  2000-02       Impact factor: 1.538

6.  Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression.

Authors:  N Arai; D Nomura; D Villaret; R DeWaal Malefijt; M Seiki; M Yoshida; S Minoshima; R Fukuyama; M Maekawa; J Kudoh
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

7.  Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels.

Authors:  I Suzuki; N Hizawa; E Yamaguchi; Y Kawakami
Journal:  Clin Exp Allergy       Date:  2000-12       Impact factor: 5.018

8.  Polymorphisms in IL4 and iLARA confer susceptibility to asthma.

Authors:  A A Amirzargar; M Movahedi; N Rezaei; B Moradi; S Dorkhosh; M Mahloji; S A Mahdaviani
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

Review 9.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

10.  Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.

Authors:  Xiang Yang Zhang; Dong Feng Zhou; Lian Yuan Cao; Pei Yan Zhang; Gui Ying Wu; Yu Cun Shen
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

View more
  2 in total

1.  Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.

Authors:  Kinga Szymona; Barbara Zdzisińska; Hanna Karakuła-Juchnowicz; Tomasz Kocki; Martyna Kandefer-Szerszeń; Marta Flis; Wojciech Rosa; Ewa M Urbańska
Journal:  Neurotox Res       Date:  2017-03-08       Impact factor: 3.911

2.  Analysis of IL-33 gene polymorphism (rs11792633 C/T) and risk of schizophrenia.

Authors:  Dor Mohammad Kordi-Tamandani; Ahmad Reza Bahrami; Raziye Sabbaghi-Ghale-No; Hanieh Soleimani; Tayebe Baranzehi
Journal:  Mol Biol Res Commun       Date:  2016-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.